Skip to content
  • About us
  • Contact us

SIRIO MEDICINE

Research Network

The lack of a mortality benefit may be associated with low baseline LDL-C levels

Posted on April 25, 2018 by siriomedicine

Association Between Baseline LDL-C Level and Total and Cardiovascular Mortality After LDL-C Lowering: A Systematic Review and Meta-analysis. Navarese EP,… Read more The lack of a mortality benefit may be associated with low baseline LDL-C levels

ICD for Primary Prevention in Patients With Ischemic or Nonischemic Cardiomyopaty

Posted on April 25, 2018April 25, 2018 by siriomedicine

Implantable Cardioverter-Defibrillators for Primary Prevention in Patients With Ischemic or Nonischemic Cardiomyopathy: A Systematic Review and Meta-analysis. Kolodziejczak M, Andreotti… Read more ICD for Primary Prevention in Patients With Ischemic or Nonischemic Cardiomyopaty

Annals of Internal Medicine: Mortality reduction with PCSK9 Antibodies

Posted on April 27, 2015April 27, 2015 by siriomedicine

Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia: A Systematic Review and Meta-analysis Eliano Pio Navarese, Michalina Kołodziejczak,… Read more Annals of Internal Medicine: Mortality reduction with PCSK9 Antibodies

BMJ meta-analysis: optimal DAPT duration after PCI with DES

Posted on April 23, 2015April 23, 2015 by siriomedicine

Available under Open Access Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised… Read more BMJ meta-analysis: optimal DAPT duration after PCI with DES

ACCRUE: individual AMI patient meta-analysis of cell-based cardiac studies

Posted on March 20, 2015March 20, 2015 by siriomedicine

Avaliable under Open Access Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in Patients with Acute Myocardial Infarction Based on Individual Patient… Read more ACCRUE: individual AMI patient meta-analysis of cell-based cardiac studies

SIRIO MEDICINE in JACC: cardiovascular Interventions

Posted on November 18, 2014December 14, 2014 by siriomedicine

Comprehensive Meta-analysis of Safety and Efficacy of Bivalirudin Versus Heparin With or Without Routine Glycoprotein IIb/IIIa Inhibitors in Patients With… Read more SIRIO MEDICINE in JACC: cardiovascular Interventions

BMJ LATEST RESEARCH: SIRIO MEDICINE’S network meta-analysis

Posted on November 9, 2013April 27, 2015 by siriomedicine

Available under Open Access Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus… Read more BMJ LATEST RESEARCH: SIRIO MEDICINE’S network meta-analysis

Meta-analysis of impact of different types and doses of statins on new-onset diabetes mellitus

Posted on August 26, 2013October 16, 2013 by siriomedicine

Meta-analysis of impact of different types and doses of statins on new-onset diabetes mellitus. Am J Cardiol. 2013 Apr 15;111(8):1123-30. doi: 10.1016/j.amjcard.2012.12.037. Epub… Read more Meta-analysis of impact of different types and doses of statins on new-onset diabetes mellitus

PCSK9 inibition is tied with improved outcomes in severe COVID-19

Posted on January 13, 2024 by siriomedicine

The intensity of inflammation during COVID-19 is related to adverse outcomes. Proprotein convertase subtilisin/kexin type 9 (PCSK9) is involved in… Read more PCSK9 inibition is tied with improved outcomes in severe COVID-19

Intracoronary epinephrine can significantly impact no-reflow in primary PCI after failure of other strategies: a novel effective therapy

Posted on October 3, 2020 by siriomedicine

The RESTORE-SIRIO study showed that as compared to use of conventional agents alone, Intracoronary epinephrine provides substantial improvement of coronary… Read more Intracoronary epinephrine can significantly impact no-reflow in primary PCI after failure of other strategies: a novel effective therapy

Prevention of CIAKI in patients undergoing cardiovascular procedures – network meta-analysis

Posted on April 25, 2018April 25, 2018 by siriomedicine

Prevention of contrast-induced acute kidney injury in patients undergoing cardiovascular procedures-a systematic review and network meta-analysis. Navarese EP, Gurbel PA,… Read more Prevention of CIAKI in patients undergoing cardiovascular procedures – network meta-analysis

The PCSK9-REACT study

Posted on November 13, 2016 by siriomedicine

Association of PCSK9 with platelet reactivity in patients with acute coronary syndrome treated with prasugrel or ticagrelor: The PCSK9-REACT study.… Read more The PCSK9-REACT study

PCSK9 antibodies for ACS: A Narrative Review

Posted on November 13, 2016 by siriomedicine

Proprotein Convertase Subtilisin/Kexin Type 9 Monoclonal Antibodies for Acute Coronary Syndrome: A Narrative Review. Navarese EP, Kolodziejczak M, Kereiakes DJ,… Read more PCSK9 antibodies for ACS: A Narrative Review

PCSK9 antibodies: Critical considerations of mortality and neurocognitive findings

Posted on November 13, 2016 by siriomedicine

Role of PCSK9 antibodies in cardiovascular disease: Critical considerations of mortality and neurocognitive findings from the current literature. Kołodziejczak M,… Read more PCSK9 antibodies: Critical considerations of mortality and neurocognitive findings

From proprotein convertase subtilisin/kexin type 9 to its inhibition: state-of-the-art and clinical implications

Posted on November 13, 2016 by siriomedicine

From proprotein convertase subtilisin/kexin type 9 to its inhibition: state-of-the-art and clinical implications Navarese EP, Kołodziejczak M, Dimitroulis D, Wolff… Read more From proprotein convertase subtilisin/kexin type 9 to its inhibition: state-of-the-art and clinical implications

Anticoagulant strategies for ACS: network meta-analysis of 42 randomised trials involving 117,353 patients

Posted on November 13, 2016 by siriomedicine

Comparative efficacy and safety of anticoagulant strategies for acute coronary syndromes. Comprehensive network meta-analysis of 42 randomised trials involving 117,353… Read more Anticoagulant strategies for ACS: network meta-analysis of 42 randomised trials involving 117,353 patients

Posts navigation

Older posts

Tags

ACS Acute coronary syndrome American Journal of Cardiology Anticoagulant Atorvastatin Atrial fibrillation Bergamo BID biodegradable polymer biolimus eluting bleeding bmj Boston Cardiology comprehensive Confidence interval contact Conventional PCI Coronary artery bypass surgery coronary intervention Diabetes mellitus Diabetes mellitus type 2 DM durable polymer drug eluting efficacy Elsevier Embase European Society of Cardiology Factor X from Google Scholar Harvard Medical School hazard ratio Health Heart disease Heparin HR Hypercholesterolemia IMS Health Internal Medicine international invasive strategy Joslin Diabetes Center LMWH Low molecular weight heparin manual thrombectomy Mechanical thrombectomy MEDLINE Meta-analysis MI Minder Myocardial infarction nste-acs nstemi odds ratio once daily OR Oral anti Xa anticoagulants Percutaneous coronary intervention QD randomized controlled trials RCTs recrutation Safety Statin statins ST elevation stents therapy thrombolysis in myocardial infarction TIMI timing twice per day United States Xa X activated

Enter your email address to follow us and receive notifications of new posts by email.

Meta

  • Create account
  • Log in
  • Entries feed
  • Comments feed
  • WordPress.com
Website Built with WordPress.com.
Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy
  • Subscribe Subscribed
    • SIRIO MEDICINE
    • Join 29 other subscribers
    • Already have a WordPress.com account? Log in now.
    • SIRIO MEDICINE
    • Subscribe Subscribed
    • Sign up
    • Log in
    • Report this content
    • View site in Reader
    • Manage subscriptions
    • Collapse this bar
 

Loading Comments...